Protecting Preterm Infants From Respiratory Tract Infections and Wheeze by Using Bacterial Lysates.
Status:
Not yet recruiting
Trial end date:
2026-04-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to reduce respiratory tract infections and wheezing in
moderate-late preterms in the first year of life by bacterial lysate administration. Next to
determine the correlation of biological markers with respiratory symptoms, immune protection
and treatment effect.
Phase:
Phase 3
Details
Lead Sponsor:
Franciscus Gasthuis
Collaborators:
Leiden University Medical Center Maastricht University Medical Center